CIK 0000811641 · Non-accelerated filer<br>Smaller reporting company
IMMUCELL CORP /DE/
Sign in to watch- Ticker
- ICCC
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010382980
- Phone
- 2078782770
- Business address
- 56 EVERGREEN DR, PORTLAND, ME, 04103
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-13 | Tomsche David Scott Director | Returned to the company | +300 | $5.24 | $2K | 97,126 |
| 2023-03-13 | Tomsche David Scott Director | Returned to the company | +200 | $5.25 | $1K | 97,326 |
| 2023-03-13 | Tomsche David Scott Director | Returned to the company | +900 | $5.37 | $5K | 98,226 |
| 2023-03-13 | Tomsche David Scott Director | Returned to the company | +80 | $5.34 | $427 | 98,306 |
| 2023-03-13 | Tomsche David Scott Director | Returned to the company | +3 | $5.24 | $16 | 98,309 |
| 2023-03-13 | Tomsche David Scott Director | Returned to the company | +7 | $5.24 | $37 | 98,316 |
| 2023-03-13 | Tomsche David Scott Director | Returned to the company | +10 | $5.23 | $52 | 98,326 |
| 2023-03-13 | Tomsche David Scott Director | Returned to the company | +100 | $5.24 | $524 | 98,426 |
| 2023-03-13 | Tomsche David Scott Director | Returned to the company | +100 | $5.24 | $524 | 98,526 |
| 2022-12-15 | Wainman Paul R Director | Grant or award · Non Qualified Stock Options (Right to buy) | +10,000 | $6.52 | $65K | 10,000 |
| 2022-12-15 | Tomsche David Scott Director | Grant or award · Non Qualified Stock Options (Right to buy) | +10,000 | $6.52 | $65K | 10,000 |
| 2022-12-15 | Rosgen Steven T. Director | Grant or award · Non Qualified Stock Options (Right to buy) | +10,000 | $6.52 | $65K | 10,000 |
| 2022-12-15 | Cunningham David Director | Grant or award · Non Qualified Stock Options (Right to buy) | +10,000 | $6.52 | $65K | 10,000 |
| 2022-12-15 | Basse Gloria F Director | Grant or award · Non Qualified Stock Options (Right to buy) | +10,000 | $6.52 | $65K | 10,000 |
| 2022-09-12 | Tomsche David Scott Director | Returned to the company | +606 | $7.75 | $5K | 96,231 |
| 2022-09-12 | Tomsche David Scott Director | Returned to the company | +195 | $7.80 | $2K | 96,426 |
| 2022-09-09 | Tomsche David Scott Director | Returned to the company | +647 | $7.76 | $5K | 95,572 |
| 2022-09-09 | Tomsche David Scott Director | Returned to the company | +33 | $7.80 | $257 | 95,605 |
| 2022-09-09 | Tomsche David Scott Director | Returned to the company | +20 | $7.70 | $154 | 95,625 |
| 2022-09-08 | Tomsche David Scott Director | Returned to the company | +306 | $7.68 | $2K | 94,325 |
Page 4 of 11 · 209 trades